Advanced Cardiovascular Systems, Inc. develops and manufactures cardiovascular medical products. It operates as a subsidiary of Abbott Laboratories. Its medical devices help patients with heart diseases in returning to active and productive lives and physicians for improving patient management and clinical outcomes. Advanced Cardiovascular Systems, Inc. is based in Santa Clara, California. it is currently known as Abbott Cardiovascular Systems.

Entellus Medical is focused on providing unique solutions to the unmet needs of the ENT (ear, nose and throat) physician, their patients, and payers through the development of innovative device technology and treatment solutions. Entellus is based in Maple Grove, MN and markets products throughout the United States. Entellus Medical works closely with leading researchers and clinicians to develop solutions that benefit patients, physicians, and payers. Entellus provides a simple, direct and effective treatment for Chronic Rhinosinusitis (CRS) that is less invasive, reduces pain and bleeding, shortens recovery time, and eliminates the need for general anesthesia. Entellus recently introduced FinESSâ„¢ Sinus Treatment, a simple and direct approach to effectively treat patients with CRS. FinESS can be performed under local anesthesia, with or without light sedation, and remodels the maxillary ostium and the ethmoid infundibulum using a micro endoscope and a small balloon catheter. Unlike sinus surgery techniques, FinESS does not require the removal of delicate bone or sinus tissue, resulting in shorter treatment time with very little pain or bleeding. Recovery time is usually one to two days with many patients resuming normal activity within a day.

Acclarent, Inc. is a medical device company in Menlo Park, CA that was established in June of 2004. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplastyâ„¢ devices. Through the Balloon Sinuplastyâ„¢ technology and our RelievaÂ:registered: product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year. Through our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT.

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China.

SCIMED Life Systems is a Manufacturing company.

Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.

Bard Peripheral Vascular, Inc., a subsidiary of Becton, Dickinson & Co., is an American company located in Tempe, AZ. The firm provides surgical and interventional devices for peripheral vascular patency.

Schneider GmbH & Co. KG manufactures optical products. Its products include ophthalmics, precision optics, and ultra-precision optics and tool systems. The company was founded by Gunter Schneider in 1986 and is headquartered in Fronhausen, Germany.

Shanghai Bio-Heart Biological Technology Co., Ltd. engages in the research and development of interventional cardiovascular device therapies. It focuses on bioresorbable scaffold therapy addressing the unmet medical needs of Chinese patients for the treatment of coronary or peripheral artery diseases; and renal denervation therapy addressing the unmet medical needs of patients for the treatment of uncontrolled hypertension and resistant hypertension. The company was founded by Li Wang and Guo Hui Wang on July 18, 2014 and is headquartered in Shanghai, China.

Polyrey Medical Tech (Suzhou) Co., Ltd. engages in the development, manufacture, and sale of medical instruments in treating vascular diseases. It focuses on coronary catheterization and outer periphery balloon dilatation catheters. The company was founded by Lie Tang on August 3, 2011 and is headquartered in Suzhou, China.

Shanghai Hongmai Medical Technology Co., Ltd., established on 2020-04-30, Business scope includes licensed projects:Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices;Import and export;Technology Import and Export;Import and export agency.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engaged in technical consulting in the field of medical technology,Technical Services(human stem cells,Except for the development and application of genetic diagnosis and treatment technology),R&D of medical devices,Business Consulting,Production of Class I Medical Devices,Sales of Class I Medical Devices,Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BrosMed Medical Co., Ltd. operates as a medical device design and manufacturing company. It develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices. The firm’s product line consists of interventional cardiovascular catheter series and endovascular catheter series. The company was founded by Benny Lee in 2012 and is headquartered in Dongguan, China.

Shenzhen Shunmei Medical Co., Ltd., established on 2009-02-17, Business scope includes general business items:Domestic Trade;Import and export,Technology Import and Export;Cosmetics Wholesale;Cosmetics Retail;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:one,two,Technology development of three types of medical devices,production and sales;Ordinary protective mask,goggles,Technology Development of Face Masks,production and sales.Cosmetic production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Boston Scientific Ltd., part of Boston Scientific Corp., is a British company located in Hemel Hempstead. The firm distributes medical products. It was founded in 1992.\nThe company says this about itself: Boston Scientific Ltd designed, manufactured and sold transvaginal mesh (“TVM”) medical devices that were implanted into thousands of Canadian women for the treatment of Stress Urinary Incontinence (“SUI”) and Pelvic Organ Prolapse (“POP”).

Founded in 1994 by Charles Tiar, Washington Asset Management Ltd. is a hedge fund manager located in New York City. Their clients include institutions and high net-worth individuals. The firm manages the Washington U.S. Fund Ltd.

Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China.

Shanghai MicroPort Cardiovascular Technology (Group) Co., Ltd., established on 2012-08-17, The business scope includes the production of Class III6846bracket,Class III6877intravascular catheter,Sell ​​self-produced products;R&D aorta,Peripheral Vascular Interventional Therapy Medical Devices,Transfer of self-developed technology,And provide related technical services,technical consulting;engaged in medical equipment(Class I,Class II,Class III)Wholesale,import and export,commission agent(except auction),and provide related services(Does not involve state trade management,Quota involved,of license-managed goods,Apply in accordance with relevant national regulations).[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]